Annual report

Period2025-04-01 → 2026-03-31
Filed2026-06-22
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 153
MetricValuePeriodScopeSource row
Revenue¥2.33T2025-04-01 → 2026-03-31Cons.Revenue IFRS
Revenue¥2.61T2024-04-01 → 2025-03-31Cons.Revenue IFRS
Revenue¥2.45T2023-04-01 → 2024-03-31vCons.Revenue IFRS (5-year summary)
Revenue¥2.90T2022-04-01 → 2023-03-31vCons.Revenue IFRS (5-year summary)
Revenue¥2.77T2021-04-01 → 2022-03-31vCons.Revenue IFRS (5-year summary)
Operating income¥151.7bn2025-04-01 → 2026-03-31Cons.Operating profit loss IFRS
Operating income¥193.0bn2024-04-01 → 2025-03-31Cons.Operating profit loss IFRS
Profit before tax¥116.1bn2025-04-01 → 2026-03-31Cons.Profit loss before tax IFRS
Profit before tax¥58.1bn2024-04-01 → 2025-03-31Cons.Profit loss before tax IFRS
Profit before tax−¥462.8bn2023-04-01 → 2024-03-31vCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥231m2022-04-01 → 2023-03-31vCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥251.1bn2021-04-01 → 2022-03-31vCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥60.9bn2025-04-01 → 2026-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥38.6bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥311.8bn2023-04-01 → 2024-03-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥7.0bn2022-04-01 → 2023-03-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥162.1bn2021-04-01 → 2022-03-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥115.4bn2025-04-01 → 2026-03-31Cons.Profit loss IFRS
Net income¥42.7bn2024-04-01 → 2025-03-31Cons.Profit loss IFRS
Net income−¥465.4bn2023-04-01 → 2024-03-31vCons.Profit loss IFRS (5-year summary)
Net income−¥46.9bn2022-04-01 → 2023-03-31vCons.Profit loss IFRS (5-year summary)
Net income¥186.4bn2021-04-01 → 2022-03-31vCons.Profit loss IFRS (5-year summary)
Total assets¥3.41Tat 2026-03-31Cons.Assets IFRS
Total assets¥3.44Tat 2025-03-31Cons.Assets IFRS
Total assets¥3.93Tat 2024-03-31vCons.Total assets IFRS (5-year summary)
Total assets¥4.17Tat 2023-03-31vCons.Total assets IFRS (5-year summary)
Total assets¥4.31Tat 2022-03-31vCons.Total assets IFRS (5-year summary)
Total liabilities¥2.17Tat 2026-03-31Cons.Liabilities IFRS
Total liabilities¥2.37Tat 2025-03-31Cons.Liabilities IFRS
Net assets / equity¥1.24Tat 2026-03-31Cons.Equity IFRS
Net assets / equity¥1.07Tat 2025-03-31Cons.Equity IFRS
Net assets / equity¥1.16Tat 2024-03-31vCons.Equity IFRS
Equity (owners)¥1.01Tat 2026-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥900.8bnat 2025-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥965.8bnat 2024-03-31vCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥1.17Tat 2023-03-31vCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥1.22Tat 2022-03-31vCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥208.6bnat 2026-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥209.8bnat 2025-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥217.4bnat 2024-03-31vCons.Cash and cash equivalents IFRS
Cash & equivalents¥305.8bnat 2023-03-31vCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥365.4bnat 2022-03-31vCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥234.8bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥233.0bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥51.3bn2023-04-01 → 2024-03-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥111.6bn2022-04-01 → 2023-03-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥171.7bn2021-04-01 → 2022-03-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥74.8bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥85.2bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥112.2bn2023-04-01 → 2024-03-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥19.4bn2022-04-01 → 2023-03-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥115.4bn2021-04-01 → 2022-03-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥199.1bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥300.8bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥49.2bn2023-04-01 → 2024-03-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥178.5bn2022-04-01 → 2023-03-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥81.4bn2021-04-01 → 2022-03-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥37.162025-04-01 → 2026-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥23.592024-04-01 → 2025-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥-190.692023-04-01 → 2024-03-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥4.272022-04-01 → 2023-03-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥99.162021-04-01 → 2022-03-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥37.152025-04-01 → 2026-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥23.582024-04-01 → 2025-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥4.272022-04-01 → 2023-03-31vCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥610.78at 2026-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥550.37at 2025-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥590.44at 2024-03-31vCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥716.26at 2023-03-31vCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥745.03at 2022-03-31vCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio29.6%at 2026-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio26.2%at 2025-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.5%at 2024-03-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.1%at 2023-03-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.3%at 2022-03-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE6.4%2025-04-01 → 2026-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE4.1%2024-04-01 → 2025-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE-29.2%2023-04-01 → 2024-03-31vCons.Rate of return on equity IFRS (5-year summary)
ROE0.6%2022-04-01 → 2023-03-31vCons.Rate of return on equity IFRS (5-year summary)
ROE14.5%2021-04-01 → 2022-03-31vCons.Rate of return on equity IFRS (5-year summary)
Employees27,491at 2026-03-31Cons.Number of employees
Employees29,279at 2025-03-31Cons.Number of employees
Employees32,161at 2024-03-31vCons.Number of employees
Employees33,572at 2023-03-31vCons.Number of employees
Employees34,703at 2022-03-31vCons.Number of employees
Revenue¥758.2bn2025-04-01 → 2026-03-31StandaloneNet sales
Revenue¥856.6bn2024-04-01 → 2025-03-31StandaloneNet sales
Revenue¥809.6bn2023-04-01 → 2024-03-31vStandaloneNet sales (5-year summary)
Revenue¥894.4bn2022-04-01 → 2023-03-31vStandaloneNet sales (5-year summary)
Revenue¥797.4bn2021-04-01 → 2022-03-31vStandaloneNet sales (5-year summary)
Operating income¥35.2bn2025-04-01 → 2026-03-31StandaloneOperating income
Operating income¥59.7bn2024-04-01 → 2025-03-31StandaloneOperating income
Ordinary income¥60.0bn2025-04-01 → 2026-03-31StandaloneOrdinary income
Ordinary income¥84.9bn2024-04-01 → 2025-03-31StandaloneOrdinary income
Ordinary income¥53.4bn2023-04-01 → 2024-03-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥69.5bn2022-04-01 → 2023-03-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥68.5bn2021-04-01 → 2022-03-31vStandaloneOrdinary income loss (5-year summary)
Profit before tax¥29.3bn2025-04-01 → 2026-03-31StandaloneIncome before income taxes
Profit before tax¥42.9bn2024-04-01 → 2025-03-31StandaloneIncome before income taxes
Net income¥32.1bn2025-04-01 → 2026-03-31StandaloneProfit loss
Net income¥24.2bn2024-04-01 → 2025-03-31StandaloneProfit loss
Net income¥8.7bn2023-04-01 → 2024-03-31vStandaloneNet income loss (5-year summary)
Net income¥50.4bn2022-04-01 → 2023-03-31vStandaloneNet income loss (5-year summary)
Net income¥61.7bn2021-04-01 → 2022-03-31vStandaloneNet income loss (5-year summary)
Total assets¥1.70Tat 2026-03-31StandaloneAssets
Total assets¥1.82Tat 2025-03-31StandaloneAssets
Total assets¥1.90Tat 2024-03-31vStandaloneTotal assets (5-year summary)
Total assets¥1.77Tat 2023-03-31vStandaloneTotal assets (5-year summary)
Total assets¥1.74Tat 2022-03-31vStandaloneTotal assets (5-year summary)
Total liabilities¥1.28Tat 2026-03-31StandaloneLiabilities
Total liabilities¥1.42Tat 2025-03-31StandaloneLiabilities
Net assets / equity¥421.6bnat 2026-03-31StandaloneNet assets
Net assets / equity¥393.9bnat 2025-03-31StandaloneNet assets
Net assets / equity¥370.4bnat 2024-03-31vStandaloneNet assets
Net assets / equity¥378.0bnat 2023-03-31vStandaloneNet assets (5-year summary)
Net assets / equity¥368.8bnat 2022-03-31vStandaloneNet assets (5-year summary)
Cash and deposits¥23.8bnat 2026-03-31StandaloneCash and deposits
Cash and deposits¥85.7bnat 2025-03-31StandaloneCash and deposits
EPS (basic)¥19.572025-04-01 → 2026-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥14.772024-04-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥5.322023-04-01 → 2024-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥30.852022-04-01 → 2023-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥37.762021-04-01 → 2022-03-31vStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥13.52025-04-01 → 2026-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥92024-04-01 → 2025-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥92023-04-01 → 2024-03-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥182022-04-01 → 2023-03-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥242021-04-01 → 2022-03-31vStandaloneDividend paid per share (5-year summary)
Net assets per share¥255.28at 2026-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥240.68at 2025-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥226.42at 2024-03-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥231.14at 2023-03-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥225.56at 2022-03-31vStandaloneNet assets per share (5-year summary)
Equity ratio24.8%at 2026-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio21.7%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio19.5%at 2024-03-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio21.3%at 2023-03-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio21.2%at 2022-03-31vStandaloneEquity to asset ratio (5-year summary)
ROE7.9%2025-04-01 → 2026-03-31StandaloneRate of return on equity (5-year summary)
ROE6.3%2024-04-01 → 2025-03-31StandaloneRate of return on equity (5-year summary)
ROE2.3%2023-04-01 → 2024-03-31vStandaloneRate of return on equity (5-year summary)
ROE13.5%2022-04-01 → 2023-03-31vStandaloneRate of return on equity (5-year summary)
ROE17.3%2021-04-01 → 2022-03-31vStandaloneRate of return on equity (5-year summary)
Shares issued1,657,914,000at 2026-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,657,217,000at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,656,449,000at 2024-03-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued1,655,860,000at 2023-03-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued1,655,446,000at 2022-03-31vStandaloneTotal number of issued shares (5-year summary)
Employees6,465at 2026-03-31StandaloneNumber of employees
Employees6,669at 2025-03-31StandaloneNumber of employees
Employees6,706at 2024-03-31vStandaloneNumber of employees
Employees6,637at 2023-03-31vStandaloneNumber of employees
Employees6,488at 2022-03-31vStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 104
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentscapex2025-04-01 → 2026-03-31¥7.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2026-03-311305 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-04-01 → 2026-03-31¥94.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-04-01 → 2026-03-31¥45.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-04-01 → 2026-03-31¥49.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2026-03-31¥231.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-04-01 → 2026-03-31¥4.4bn
Reconciling Itemsreconcilingcapex2025-04-01 → 2026-03-31¥9.6bn
Reconciling Itemsreconcilingrevenue2025-04-01 → 2026-03-31−¥70.8bn
Reconciling Itemsreconcilingrevenue intersegment2025-04-01 → 2026-03-31−¥70.8bn
Reconciling Itemsreconcilingsegment assetsat 2026-03-31¥80.9bn
Reconciling Itemsreconcilingsegment profit2025-04-01 → 2026-03-31−¥31.1bn
Advanced Medical Solutionsreportable segmentcapex2025-04-01 → 2026-03-31¥9.6bn
Advanced Medical Solutionsreportable segmentemployeesat 2026-03-312161 pure
Advanced Medical Solutionsreportable segmentrevenue2025-04-01 → 2026-03-31¥72.4bn
Advanced Medical Solutionsreportable segmentrevenue external2025-04-01 → 2026-03-31¥58.6bn
Advanced Medical Solutionsreportable segmentrevenue intersegment2025-04-01 → 2026-03-31¥13.8bn
Advanced Medical Solutionsreportable segmentsegment assetsat 2026-03-31¥125.2bn
Advanced Medical Solutionsreportable segmentsegment profit2025-04-01 → 2026-03-31¥2.8bn
Agro And Life Solutionsreportable segmentcapex2025-04-01 → 2026-03-31¥15.8bn
Agro And Life Solutionsreportable segmentemployeesat 2026-03-317016 pure
Agro And Life Solutionsreportable segmentrevenue2025-04-01 → 2026-03-31¥520.4bn
Agro And Life Solutionsreportable segmentrevenue external2025-04-01 → 2026-03-31¥519.3bn
Agro And Life Solutionsreportable segmentrevenue intersegment2025-04-01 → 2026-03-31¥1.1bn
Agro And Life Solutionsreportable segmentsegment assetsat 2026-03-31¥819.6bn
Agro And Life Solutionsreportable segmentsegment profit2025-04-01 → 2026-03-31¥56.3bn
Essential And Green Materialsreportable segmentcapex2025-04-01 → 2026-03-31¥18.2bn
Essential And Green Materialsreportable segmentemployeesat 2026-03-313030 pure
Essential And Green Materialsreportable segmentrevenue2025-04-01 → 2026-03-31¥683.4bn
Essential And Green Materialsreportable segmentrevenue external2025-04-01 → 2026-03-31¥678.8bn
Essential And Green Materialsreportable segmentrevenue intersegment2025-04-01 → 2026-03-31¥4.6bn
Essential And Green Materialsreportable segmentsegment assetsat 2026-03-31¥639.9bn
Essential And Green Materialsreportable segmentsegment profit2025-04-01 → 2026-03-31¥14.4bn
ICT And Mobility Solutionsreportable segmentcapex2025-04-01 → 2026-03-31¥53.0bn
ICT And Mobility Solutionsreportable segmentemployeesat 2026-03-319563 pure
ICT And Mobility Solutionsreportable segmentrevenue2025-04-01 → 2026-03-31¥575.1bn
ICT And Mobility Solutionsreportable segmentrevenue external2025-04-01 → 2026-03-31¥574.2bn
ICT And Mobility Solutionsreportable segmentrevenue intersegment2025-04-01 → 2026-03-31¥968m
ICT And Mobility Solutionsreportable segmentsegment assetsat 2026-03-31¥722.6bn
ICT And Mobility Solutionsreportable segmentsegment profit2025-04-01 → 2026-03-31¥53.0bn
Sumitomo Pharmareportable segmentcapex2025-04-01 → 2026-03-31¥8.1bn
Sumitomo Pharmareportable segmentemployeesat 2026-03-313112 pure
Sumitomo Pharmareportable segmentrevenue2025-04-01 → 2026-03-31¥453.3bn
Sumitomo Pharmareportable segmentrevenue external2025-04-01 → 2026-03-31¥451.9bn
Sumitomo Pharmareportable segmentrevenue intersegment2025-04-01 → 2026-03-31¥1.4bn
Sumitomo Pharmareportable segmentsegment assetsat 2026-03-31¥785.9bn
Sumitomo Pharmareportable segmentsegment profit2025-04-01 → 2026-03-31¥108.4bn
—segment totalcapex2025-04-01 → 2026-03-31¥104.7bn
—segment totalrevenue2025-04-01 → 2026-03-31¥2.30T
—segment totalrevenue external2025-04-01 → 2026-03-31¥2.28T
—segment totalrevenue intersegment2025-04-01 → 2026-03-31¥21.8bn
—segment totalsegment assetsat 2026-03-31¥3.09T
—segment totalsegment profit2025-04-01 → 2026-03-31¥235.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentscapex2024-04-01 → 2025-03-31¥4.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2025-03-31¥165.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2025-03-31¥99.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2025-03-31¥65.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2025-03-31¥284.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2025-03-31¥66.9bn
Reconciling Itemsreconcilingcapex2024-04-01 → 2025-03-31¥7.2bn
Reconciling Itemsreconcilingrevenue2024-04-01 → 2025-03-31−¥85.4bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2025-03-31−¥85.4bn
Reconciling Itemsreconcilingsegment assetsat 2025-03-31¥102.2bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2025-03-31−¥32.7bn
Advanced Medical Solutionsreportable segmentcapex2024-04-01 → 2025-03-31¥13.0bn
Advanced Medical Solutionsreportable segmentrevenue2024-04-01 → 2025-03-31¥72.5bn
Advanced Medical Solutionsreportable segmentrevenue external2024-04-01 → 2025-03-31¥62.1bn
Advanced Medical Solutionsreportable segmentrevenue intersegment2024-04-01 → 2025-03-31¥10.4bn
Advanced Medical Solutionsreportable segmentsegment assetsat 2025-03-31¥125.3bn
Advanced Medical Solutionsreportable segmentsegment profit2024-04-01 → 2025-03-31¥4.0bn
Agro And Life Solutionsreportable segmentcapex2024-04-01 → 2025-03-31¥20.1bn
Agro And Life Solutionsreportable segmentrevenue2024-04-01 → 2025-03-31¥541.3bn
Agro And Life Solutionsreportable segmentrevenue external2024-04-01 → 2025-03-31¥540.2bn
Agro And Life Solutionsreportable segmentrevenue intersegment2024-04-01 → 2025-03-31¥1.1bn
Agro And Life Solutionsreportable segmentsegment assetsat 2025-03-31¥771.3bn
Agro And Life Solutionsreportable segmentsegment profit2024-04-01 → 2025-03-31¥55.0bn
Essential And Green Materialsreportable segmentcapex2024-04-01 → 2025-03-31¥26.3bn
Essential And Green Materialsreportable segmentrevenue2024-04-01 → 2025-03-31¥903.9bn
Essential And Green Materialsreportable segmentrevenue external2024-04-01 → 2025-03-31¥899.0bn
Essential And Green Materialsreportable segmentrevenue intersegment2024-04-01 → 2025-03-31¥4.9bn
Essential And Green Materialsreportable segmentsegment assetsat 2025-03-31¥791.9bn
Essential And Green Materialsreportable segmentsegment profit2024-04-01 → 2025-03-31−¥58.5bn
ICT And Mobility Solutionsreportable segmentcapex2024-04-01 → 2025-03-31¥49.2bn
ICT And Mobility Solutionsreportable segmentrevenue2024-04-01 → 2025-03-31¥610.3bn
ICT And Mobility Solutionsreportable segmentrevenue external2024-04-01 → 2025-03-31¥607.0bn
ICT And Mobility Solutionsreportable segmentrevenue intersegment2024-04-01 → 2025-03-31¥3.3bn
ICT And Mobility Solutionsreportable segmentsegment assetsat 2025-03-31¥635.7bn
ICT And Mobility Solutionsreportable segmentsegment profit2024-04-01 → 2025-03-31¥70.6bn
Sumitomo Pharmareportable segmentcapex2024-04-01 → 2025-03-31¥11.5bn
Sumitomo Pharmareportable segmentrevenue2024-04-01 → 2025-03-31¥398.5bn
Sumitomo Pharmareportable segmentrevenue external2024-04-01 → 2025-03-31¥398.0bn
Sumitomo Pharmareportable segmentrevenue intersegment2024-04-01 → 2025-03-31¥529m
Sumitomo Pharmareportable segmentsegment assetsat 2025-03-31¥728.7bn
Sumitomo Pharmareportable segmentsegment profit2024-04-01 → 2025-03-31¥35.3bn
—segment totalcapex2024-04-01 → 2025-03-31¥120.1bn
—segment totalrevenue2024-04-01 → 2025-03-31¥2.53T
—segment totalrevenue external2024-04-01 → 2025-03-31¥2.51T
—segment totalrevenue intersegment2024-04-01 → 2025-03-31¥20.2bn
—segment totalsegment assetsat 2025-03-31¥3.05T
—segment totalsegment profit2024-04-01 → 2025-03-31¥106.4bn
Advanced Medical Solutionsreportable segmentemployeesat 2026-03-31648 pure
Agro And Life Solutionsreportable segmentemployeesat 2026-03-311445 pure
Essential And Green Materialsreportable segmentemployeesat 2026-03-311374 pure
ICT And Mobility Solutionsreportable segmentemployeesat 2026-03-311862 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 2,628
ItemContextValueUnit
Repayments of lease obligations fin cf IFRSCurrentYearDuration-20643000000JPY
Proceeds from sale and leaseback transactions fin cf IFRSPrior1YearDuration6700000000JPY
Proceeds from sale and leaseback transactions fin cf IFRSCurrentYearDuration-JPY
Dividends paid fin cf IFRSPrior1YearDuration-9866000000JPY
Dividends paid fin cf IFRSCurrentYearDuration-19680000000JPY
Dividends paid to non controlling interests fin cf IFRSPrior1YearDuration-11698000000JPY
Dividends paid to non controlling interests fin cf IFRSCurrentYearDuration-1662000000JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSPrior1YearDuration-5330000000JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSCurrentYearDuration-2245000000JPY
Other fin cf IFRSPrior1YearDuration896000000JPY
Other fin cf IFRSCurrentYearDuration-2092000000JPY
Net cash provided by used in financing activities IFRSPrior1YearDuration-300778000000JPY
Net cash provided by used in financing activities IFRSCurrentYearDuration-199068000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YearDuration-6823000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYearDuration15657000000JPY
Net increase decrease in cash and cash equivalents IFRSPrior1YearDuration10655000000JPY
Net increase decrease in cash and cash equivalents IFRSCurrentYearDuration-23473000000JPY
Cash and cash equivalents IFRSPrior2YearInstant217449000000JPY
Cash and cash equivalents IFRSPrior1YearInstant209838000000JPY
Net increase decrease in cash and cash equivalents resulting from transfer to assets held for sale IFRSPrior1YearDuration-18266000000JPY
Net increase decrease in cash and cash equivalents resulting from transfer to assets held for sale IFRSCurrentYearDuration22224000000JPY
Cash and cash equivalents IFRSPrior1YearInstant209838000000JPY
Cash and cash equivalents IFRSCurrentYearInstant208589000000JPY
Revenue from external customers IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000AgroAndLifeSolutionsReportableSegmentMember540221000000JPY
Revenue from external customers IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000ICTAndMobilitySolutionsReportableSegmentMember606995000000JPY
Revenue from external customers IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000AdvancedMedicalSolutionsReportableSegmentMember62145000000JPY
Revenue from external customers IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000EssentialAndGreenMaterialsReportableSegmentMember899029000000JPY
Revenue from external customers IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000SumitomoPharmaReportableSegmentMember398001000000JPY
Revenue from external customers IFRSPrior1YearDuration_ReportableSegmentsMember2506391000000JPY
Revenue from external customers IFRSPrior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember99890000000JPY
Revenue from external customers IFRSPrior1YearDuration_ReconcilingItemsMember-JPY
Revenue from external customers IFRSPrior1YearDuration2606281000000JPY
Intersegment revenue IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000AgroAndLifeSolutionsReportableSegmentMember1114000000JPY
Intersegment revenue IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000ICTAndMobilitySolutionsReportableSegmentMember3258000000JPY
Intersegment revenue IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000AdvancedMedicalSolutionsReportableSegmentMember10388000000JPY
Intersegment revenue IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000EssentialAndGreenMaterialsReportableSegmentMember4874000000JPY
Intersegment revenue IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000SumitomoPharmaReportableSegmentMember529000000JPY
Intersegment revenue IFRSPrior1YearDuration_ReportableSegmentsMember20163000000JPY
Intersegment revenue IFRSPrior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember65195000000JPY
Intersegment revenue IFRSPrior1YearDuration_ReconcilingItemsMember-85358000000JPY
Intersegment revenue IFRSPrior1YearDuration-JPY
Revenue IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000AgroAndLifeSolutionsReportableSegmentMember541335000000JPY
Revenue IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000ICTAndMobilitySolutionsReportableSegmentMember610253000000JPY
Revenue IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000AdvancedMedicalSolutionsReportableSegmentMember72533000000JPY
Revenue IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000EssentialAndGreenMaterialsReportableSegmentMember903903000000JPY
Revenue IFRSPrior1YearDuration_jpcrp030000-asr_E00752-000SumitomoPharmaReportableSegmentMember398530000000JPY
Revenue IFRSPrior1YearDuration_ReportableSegmentsMember2526554000000JPY
Revenue IFRSPrior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember165085000000JPY
Revenue IFRSPrior1YearDuration_ReconcilingItemsMember-85358000000JPY
Revenue IFRSPrior1YearDuration2606281000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2026-03-31pass
balance sheet identitynon_consolidated 2025-03-31pass
balance sheet identitynon_consolidated 2026-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · net assetsnon_consolidated 2026-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2025-03-31pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2026-03-31pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2025-03-31pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2026-03-31pass
statement vs summary · revenueconsolidated 2024-04-01/2025-03-31pass
statement vs summary · revenueconsolidated 2025-04-01/2026-03-31pass
statement vs summary · revenuenon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · revenuenon_consolidated 2025-04-01/2026-03-31pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2026-03-31pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass
statement vs summary · total assetsnon_consolidated 2026-03-31pass